GOSS Hisse Senedi Fiyat Grafiği
GOSS Kazanmak
Gossamer Bio Inc
$0.33
3.57%
$0.01
Kapanışta: May 11, 16:00:00 GMT-4
$0.33
-1.68%
$0
Sonrası Piyasa: May 11, 17:52:39 GMT-4
Geri
Gossamer Bio Inc (GOSS) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$0.327
Açılış fiyatı
$0.3248
Günün Aralığı
$0.3142 - $0.3387
52 haftalık aralık
$0.32 - $3.87
İşlem hacmi
2.8M
Ort.Hacim
12.7M
Dividend yield
--
EPS (TTM)
-0.74
Piyasa Değeri
$77.0M
GOSS nedir?
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company is headquartered in San Diego, California. The company went IPO on 2019-02-08. Seralutinib, also known as GB002, is an investigational inhaled, small-molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor, being evaluated in a Phase III clinical trial for the treatment of PAH. Seralutinib is designed to target the mechanisms that underlie pulmonary hypertension and to be delivered to the site of disease, via dry powder inhaler. Seralutinib is being evaluated in a Phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH). Inhaled seralutinib, which is designed to act on both isoforms of the PDGFR, α and β, as well as the CSF1R and c-KIT pathways.
